本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aktis Oncology

17.34
-0.8100-4.46%
成交量:27.41万
成交额:479.26万
市值:9.58亿
市盈率:-12.68
高:18.19
开:18.12
低:17.31
收:18.15
52周最高:34.19
52周最低:14.72
股本:5,527.60万
流通股本:1,765.00万
量比:0.79
换手率:1.55%
股息:- -
股息率:- -
每股收益(TTM):-1.3680
每股收益(LYR):-78.3394
净资产收益率:-29.45%
总资产收益率:-15.79%
市净率:1.98
市盈率(LYR):-0.22

数据加载中...

2026/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/05

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/12/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/18

重要事件披露

Form 8-K - Current report
2024/12/16

重要事件披露

Form 8-K - Current report